Incorporation of isoniazid in clay minerals: a study review/ Incorporação de isoniazida em minerais argilosos: uma revisão do estudo


  • Gilmar de Oliveira Pinheiro
  • Jumara Batista
  • Thamyres Carvalho
  • Jessica Arjona
  • Vitoria Souza de Oliveira Nascimento
  • Margarita Gaviria
  • Francisco Rolando Valenzuela Diaz



clay, tuberculosis, isoniazid, intercalation, controlled release .


Tuberculosis is a globally widespread infectious disease with elevated transmissibility and expressive mortality rate. It affects people throughout all age groups causing a strong economic impact on public health systems. Isoniazid, which was launched in the market in the 60’s, has been the most effective antimicrobial drug for the treatment of tuberculosis so far. However, this is a long treatment with many adverse effects resulting in poor patient compliance. Therefore, it is necessary to develop oral intake systems that minimize the adverse effects of the drug to guarantee patients adherence to the treatment. Over the last decade, extensive research has shown that the development of controlled release systems is an effective way of addressing isoniazid’s adverse effects. The intercalation of isoniazid in clay minerals such as bentonites present highly promising results. The present study review seeks to summarize and allow readers to understand the most recent published articles and research on this subject.


AKYUZ, S.; AKYUZ, T. FT-IR and FT-Raman spectroscopic studies of adsorption of isoniazid by montmorillonite and saponite. Vibrational Spectroscopy, v. 48, n. 2, p. 229–232, 2008.

AKYUZ, S.; AKYUZ, T.; AKALIN, E. Adsorption of isoniazid onto sepiolite-palygorskite group of clays: An IR study. Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, v. 75, n. 4, p. 1304–1307, abr. 2010.

ALLAND, D. et al. Identification of differentially expressed mRNA in prokaryotic organisms by customized amplification libraries (DECAL): The effect of isoniazid on gene expression in Mycobacterium tuberculosis. Proceedings of the National Academy of Sciences of the United States of America, v. 95, n. 22, p. 13227–13232, 1998.

AMARNATH PRAPHAKAR, R. et al. Phosphorylated κ-Carrageenan-Facilitated Chitosan Nanovehicle for Sustainable Anti-Tuberculosis Multi Drug Delivery. ChemistrySelect, v. 2, n. 24, p. 7100–7107, 2017.

ANNABI-BERGAYA, F. Layered clay minerals. Basic research and innovative composite applications. Microporous and Mesoporous Materials, v. 107, n. 1–2, p. 141–148, 2008.

BANIK, N. et al. Preparation and evaluation of the effect of particle size on the properties of chitosan-montmorillonite nanoparticles loaded with isoniazid. RSC Advances, v. 2, n. 28, p. 10519–10528, 14 nov. 2012.

BANIK, N. et al. Soy flour nanoparticles for controlled drug delivery: Effect of crosslinker and montmorillonite (MMT). New Journal of Chemistry, v. 37, n. 12, p. 3981–3990, 2013.

BANIK, N.; RAMTEKE, A.; MAJI, T. K. Carboxymethyl chitosan-montmorillonite nanoparticles for controlled delivery of isoniazid: evaluation of the effect of the glutaraldehyde and montmorillonite. Polymers for Advanced Technologies, v. 25, n. 12, p. 1580–1589, dez. 2014.

BERGAYA, F.; THENG, B.; LAGALY, G. Handbook of Clay Science. In: ELSEVIER (Ed.). . Handbook of Clay Science. 4th. ed. San Diego - California: Elsevier, 2005.

BIZERRA, A.; SILVA, V. SISTEMAS DE LIBERAÇÃO CONTROLADA: Mecanismos e aplicações. Revista Saúde e Meio Ambiente-RESMA, n. 2, p. 1–12, 2016.

ÇALIŞKAN SALIHI, E.; GÜNDÜZ, Z.; BAŞTUĞ, A. S. Fast retention of isoniazid on organobentonite prepared using green chemistry approach: contribution of the π interactions. Separation Science and Technology (Philadelphia), v. 54, n. 16, p. 2695–2705, 2019.

CARAZO, E. et al. Assessment of halloysite nanotubes as vehicles of isoniazid. Colloids and Surfaces B: Biointerfaces, v. 160, p. 337–344, 2017.

CARAZO, E. et al. Kinetic and thermodynamic assessment on isoniazid/montmorillonite adsorption. Applied Clay Science, v. 165, n. August, p. 82–90, 2018a.

CARAZO, E. et al. Adsorption and characterization of palygorskite-isoniazid nanohybrids. Applied Clay Science, v. 160, p. 180–185, 1 ago. 2018b.

CARAZO, E. et al. Kinetic and thermodynamic assessment on isoniazid/montmorillonite adsorption. Applied Clay Science, v. 165, p. 82–90, 1 dez. 2018c.

CARAZO, E. et al. Halloysite nanotubes as tools to improve the actual challenge of fixed doses combinations in tuberculosis treatment. Journal of Biomedical Materials Research - Part A, v. 107, n. 7, p. 1513–1521, 1 jul. 2019.

CARRIER, E. Short Report. European Neurology, v. 42, n. 2, p. 116–117, 1999.

CHEN, G. et al. Isoniazid-loaded chitosan / carbon nanotubes microspheres promote secondary wound healing of bone tuberculosis. Mar. 2019.

DAMASCENO JUNIOR, E. et al. pH-responsive release system of isoniazid using palygorskite as a nanocarrier. Journal of Drug Delivery Science and Technology, v. 55, n. October 2019, p. 101399, 2020a.

DAMASCENO JUNIOR, E. et al. pH-responsive release system of isoniazid using palygorskite as a nanocarrier. Journal of Drug Delivery Science and Technology, v. 55, 1 fev. 2020b.

DE ALMEIDA, J. M. F. et al. pH-Dependent release system of isoniazid carried on nanoparticles of silica obtained from expanded perlite. Applied Surface Science, v. 489, n. March, p. 297–312, 2019.

DUARTE, R. et al. Tuberculosis treatment and management of some problems related to the medication. Revista Portuguesa de Pneumologia, v. 16, n. 4, p. 559–572, 2010.

ELENA, R. et al. Synthesis and Physico-chemical Characterization of Nanohybrid Materials Based on Isonicotinic Acid Hydrazide. Vol n. 2, p. 2–5, 2019.

GE, Z. et al. Pharmacokinetics of isoniazid and rifampicin-loaded bovine serum albumin nanoparticles in rabbits. Latin American Journal of Pharmacy, v. 37, n. 10, p. 1938–1944, 2018.

HANG, N. T. LE et al. Whole genome sequencing, analyses of drug resistance-conferring mutations, and correlation with transmission of Mycobacterium tuberculosis carrying katG-S315T in Hanoi, Vietnam. Scientific Reports, v. 9, n. 1, p. 1–14, 2019.

KATZUNG, B. G. Farmacologia Clínica. Nona ediçã ed. Rio de Janeiro: Editora Guanabara Koogan, 2006.

MURRAY, S.; MENDEL, C.; SPIGELMAN, M. TB Alliance regimen development for multidrug-resistant tuberculosis. International Journal of Tuberculosis and Lung Disease, v. 20, n. 12, p. S38–S41, 2016.

NKANGA, C. I.; KRAUSE, R. W. M. Encapsulation of Isoniazid-conjugated Phthalocyanine-In-Cyclodextrin-In-Liposomes Using Heating Method. Scientific Reports, v. 9, n. 1, p. 1–16, 2019.

OROFINO, R. DE L. et al. Predictors of tuberculosis treatment outcomes. Jornal brasileiro de pneumologia: publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia, v. 38, n. 1, p. 88–97, 2012.

PANDEY, G.; YADAV, S. K.; MISHRA, B. Preparation and characterization of isoniazid and lamivudine co-loaded polymeric microspheres. Artificial Cells, Nanomedicine and Biotechnology, v. 44, n. 8, p. 1867–1877, 2016.

RODRIGUES, B.; SHENDE, P. Monodispersed metal-based dendrimeric nanoclusters for potentiation of anti-tuberculosis action. Journal of Molecular Liquids, v. 304, p. 112731, 2020.

SAIKIA, C. et al. Crosslinked thiolated starch coated Fe3O4 magnetic nanoparticles: Effect of montmorillonite and crosslinking density on drug delivery properties. Starch/Staerke, v. 66, n. 7–8, p. 760–771, 2014.

SAIKIA, C. et al. Carboxymethyl starch-chitosan-coated iron oxide magnetic nanoparticles for controlled delivery of isoniazid. Journal of Microencapsulation, v. 32, n. 1, p. 29–39, 1 fev. 2015.

SARMAH, M. et al. Study on crosslinked gelatin–montmorillonite nanoparticles for controlled drug delivery applications. Journal of Materials Science, v. 50, n. 22, p. 7303–7313, 2015.

SCHUTZ, C. et al. Early antituberculosis drug exposure in hospitalized patients with human immunodeficiency virus-associated tuberculosis. British Journal of Clinical Pharmacology, n. November 2019, p. 966–978, 2020.

SOJKA, J. et al. Topical Dexamethasone and Dimethyl Sulfoxide Solutions Do Not Result in Detectable Blood Levels of Dexamethasone. Journal of Equine Veterinary Science, v. 28, n. 12, p. 739–742, 2008.

SOUZA, I. M. S. et al. Adsorption capacity evaluation of zeolites as carrier of isoniazid. Microporous and Mesoporous Materials, v. 292, 15 jan. 2020.

SOUZA, I. M. S. et al. Study of Faujasite zeolite as a modified delivery carrier for isoniazid Materials Science and Engineering Elsevier Ltd, 1 jan. 2021.

SUGUNALAKSHMI, M. et al. Inorganic clay mineral, Montmorillonite for the Adsorption of Isoniazid drug, formulations, and release studies International Journal of Recent Advances in Engineering & Technology. Vol 2, mar, 2019.

VERMA, A.; RIAZ, U. Mechanochemically synthesized poly(o-toluidine)-intercalated montmorillonite nanocomposites as antituberculosis drug carriers. International Journal of Polymeric Materials and Polymeric Biomaterials, v. 67, n. 4, p. 221–228, 21 jul. 2018.

WHO, W. H. O. The impact of COVID-19 on the TB epidemic: A community perspective. Tuberculosis Weekly report, 2020.

WILSON, N. M. et al. Airborne transmission of severe acute respiratory syndrome coronavirus-2 to healthcare workers: a narrative review. Anesthesia, April 2020.

WYSZOGRODZKA-GAWEŁ, G. et al. An inhalable theranostic system for local tuberculosis treatment containing an isoniazid loaded metal organic framework fe-mil-101-NH2—from raw MOF to drug delivery system. Pharmaceutics, v. 11, n. 12, 2019.

ZHANG, D. et al. Rapid molecular screening for multidrug-resistant tuberculosis in a resource-limited region of China. Tropical Medicine and International Health, v. 19, n. 10, p. 1259–1266, 2014.

ZYOUD, A. H. et al. Emerging integrated nano clay-facilitated drug delivery system for papillary thyroid cancer therapy. Scientific Reports, v. 6, n. June, p. 1–10, 2016.





Original Papers